Oxidation of the haem under conditions of oxidative stress as observed in NASH patients has the potential to render the sGC enzyme insensitive to NO17 making an sGC activator potentially more effective than an sGC stimulator. The gene discussed is SGCB; the disease is metabolic dysfunction-associated steatohepatitis.